Mar 9, 2020

Rab27b regulates the release, autophagic clearance, and toxicity of alpha-synuclein

bioRxiv
Rachel UnderwoodTalene Yacoubian

Abstract

Alpha synuclein (syn) is the primary component of proteinaceous aggregates termed Lewy Bodies that pathologically define synucleinopathies including Parkinsons disease (PD) and Dementia with Lewy Bodies (DLB). Syn is hypothesized to spread through the brain in a prion-like fashion by misfolded protein forming a template for aggregation of endogenous syn. The release and uptake of syn from cell to cell are considered important processes for this prion-like spread. Rab27b is one of several GTPases essential to the endosomal-lysosomal pathway and is implicated in protein secretion and clearance but has yet to be characterized in its role in syn spread. In this study, we used a paracrine syn in vitro model to test the impact of Rab27b on syn release, clearance, and toxicity. shRNA-mediated knockdown (KD) of Rab27b increased syn-mediated paracrine toxicity. While Rab27b reduced syn release primarily through non-exosomal pathways, the syn released under KD conditions was of higher molecular weight species by size exclusion chromatography. Rab27b KD increased intracellular insoluble syn levels and led to an accumulation of endogenous LC3 positive puncta. Rab27b KD also decreased LC3 turnover with chloroquine treatment, indicating a de...Continue Reading

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Release of Sequestered Calcium Ion into Cytoplasm
Chloroquine
Lewy Body Disease
Signaling Pathway in Endosome
Gene Knockdown Techniques
Exosomes
Autopsy
DLEU1
Pathogenesis
Study

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.